Abstract
Free iron is a pro-oxidant and can induce oxidative stress and DNA damage. The carcinogenicity of iron has been demonstrated in animal models, and epidemiologic studies have shown associations with several human cancers. However, a possible role of excess body iron stores or of elevated iron intake in breast carcinogenesis has received little attention epidemiologically. We propose that iron overload and the disruption of iron homeostasis with a resulting increase in free iron may contribute to the development of breast cancer, and we summarize the relevant evidence from mechanistic studies, animal experiments, and studies in humans. Over time a high intake of iron can lead to iron overload. Furthermore, body iron stores increase in women following menopause. Reactive oxygen species produced by normal aerobic cellular metabolism can lead to the release of free iron from ferritin. In the presence of superoxide radical and hydrogen peroxide, stored ferric iron (Fe3+) is reduced to ferrous iron (Fe2+), which catalyzes the formation of the hydroxyl radical (*OH). *OH in turn can promote lipid peroxidation, mutagenesis, DNA strand breaks, oncogene activation, and tumor suppressor inhibition, increasing the risk of breast cancer. In addition to its independent role as a proxidant, high levels of free iron may potentiate the effects of estradiol, ethanol, and ionizing radiation—three established risk factors for breast cancer. In order to identify the role of iron in breast carcinogenesis, improved biomarkers of body iron stores are needed, as are cohort studies which assess heme iron intake. Ultimately, it is important to determine whether iron levels in the breast and iron-induced pathology are higher in women who go on to develop breast cancer compared to women who do not.
Similar content being viewed by others
References
Toyokuni S (1996) Iron-induced carcinogenesis: the role of redox regulation. Free Rad Biol Med 20:553–566
Ponka P, Beaumont C, Richardson DR (1998) Function and regulation of transferrin and ferritin. Sem Hematol 35:35–54
McCord JM (1998) Iron, free radicals, and oxidative injury. Sem Hematol 35:5–12
Dreosti IE (2001) Zinc and the gene: review. Mutat Res 475:161–167
Reizenstein P (1991) Iron, free radicals and cancer: a review. Med Oncol Tumor Pharmacother 8:229–233
Huang X (2003) Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal. Mutat Res 533:153–171
Sahu SC (1992) Dietary iron and cancer: a review. Environ Carcino Ecotox Revs C10:205–237
Kang D-H (2002) Oxidative stress, DNA damage, and breast cancer. AACN Clin Issues 13:540–549
Marnett LJ (2000) Oxyradicals and DNA damage. Carcinogenesis 21:361–370
Castro L, Freeman BA (2001) Reactive oxygen species in human health and disease. Nutrition 17:163–165
Okada S, Hamazaki S, Ebina Y, Li J-L, Midorikawa O (1987) Nephrotoxicity and its prevention by vitamin E on ferric nitrotriacetate-promoted lipid peroxidation. Biochim Biophys Acta 922:28–33
Liehr JG, Jones JS (2001) Role of iron in estrogen-induced cancer. Current Medicinal Chem 8:839–849
Stevens RG, Beasley RP, Blumberg BS (1986) Iron-binding proteins and risk of cancer in Taiwan. J Natl Cancer Inst 76:605–610
Selby JV, Friedman GD (1988) Epidemiologic evidence of an association between body iron stores and risk of cancer. Int J Cancer 41:677–682
Stevens RG, Graubard BI, Micozzi MS, Neriishi K, Blumberg BS (1994) Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int J Cancer 56:364–369
Knekt P, Reunanen A, Takkunen H, Aromaa A, Heliovaara M, Hakulinen T (1994) Body iron stores and risk of cancer. Int J Cancer 56:379–382
Herrinton LJ, Friedman GD, Baer D, Selby JV (1995) Transferrin saturation and risk of cancer. Am J Epidemiol 142:692–698
Andrews NC, Schmidt PJ (2007) Iron homeostasis. Annu Rev Physiol 69:69–85
Fletcher LM, Halliday JW, Powell LW (1999) Interrelationships of alcohol and iron in liver disease with particular reference to the iron-binding proteins, ferritin and transferrin. J Gastroenterol Hepatol 14:202–214
Leggett BA, Brown NN, Bryant SJ, Duplock L, Powell LW, Halliday JW (1990) Factors affecting the concentrations of ferritin in serum in a healthy Australian population. Clin Chem 36:1350–1355
Malins DC, Haimanot R (1991) Major alterations in the nucleotide structure of DNA in cancer of the female breast. Cancer Res 51:5430–5432
Malins DC, Holmes EH, Polissar NL, Gunselman SJ (1993) The etiology of breast cancer: characteristic alterations in *OH radical induced DNA base lesions during carcinogenesis with potential for evaluating incidence risk. Cancer 71:3036–3043
Malins DC, Polissar NL, Gunselman SJ (1996) Progression of human breast cancers to the metastatic state is linked to *OH radical induced DNA damage. Proc Natl Acad Sci USA 93:2557–2563
Kumar K, Thangaraju M, Sachdanandam P (1991) Changes observed in antioxidant system in the blood of postmenopausal women with breast cancer. Biochem Int 25:371–380
Huang Y-L, Sheu J-Y, Lin T-H (1999) Association between oxidative stress and changes in trace elements in patients with breast cancer. Clinical Biochem 32:131–136
Ray G, Batra S, Shukla NK et al (2000) Lipid peroxidation, free radical production and antioxidant status in breast cancer. Breast Cancer Res Treat 59:163–170
Gonenc A, Ozkan Y, Torun M, Simsek B (2001) Plasma malonaldehyde (MDA) levels in breast and lung cancer patients. J Clin Pharm Ther 26:141–144
Boyd NF, McGuire V (1990) Evidence of lipid peroxidation in premenopausal women with mammographic dysplasia. Cancer Lett 50:31–37
Boyd NF, McGuire V (1991) The possible role of lipid peroxidation in breast cancer risk. Free Radic Biol Med 10:185–190
Wang M, Dhingra K, Hittelman WN, Liehr JG, de Andrade M, Li D (1996) Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues. Cancer Epidemiol Biomarkers Prev 5:705–710
Rossner P, Gammon MD, Terry MB et al (2006) Relationship between urinary 15-F2t-isoprostane and 8-oxodeoxyguanosine levels and breast cancer risk. Cancer Epidemiol Biomarkers Prev 15:639–644
Punnonen K, Ahotupa M, Asaishi K, Hyoty M, Kudo R, Punnonen R (1994) Antioxidant enzyme activities and oxidative stress in human breast cancer. J Cancer Res Clin Oncol 120:374–377
Good MF, Powell LW, Halliday JW (1988) Iron status and cellular immune competence. Blood Rev 2:43–49
Walker EM, Walker SM (2000) Effects of iron overload on the immune system. Ann Clin Lab Sci 30:354–365
de Sousa M (1989) The immunology of iron overload. In: de Sousa M, Brock JH (eds) Iron in immunity, cancer and inflammation. J. Wiley, Chichester, pp 247–258
Djeha A, Brock JH (1992) Effect of transferrin, lactoferrin and chelated iron on human T-lymphocytes. Br J Haematol 80:235–241
Weinberg JB, Hibbs JB Jr (1977) Endocytosis of red blood cells or hemoglobin by activated macrophages inhibits their tumoricidal effect. Nature 269:245–247
Milman N, Byg K-E, Ovesen L, Kirchhoff M, Jürgensen KS-L (2003) Iron status in Danish women, 1984–1994: a cohort comparison of changes in iron stores and the prevalence of iron deficiency and iron overload. Eur J Haematol 71:51–61
Fleming DJ, Jacques PF, Tucker KL et al (2001) Iron status of the free-living, elderly Framingham Heart Study cohort: an iron-replete population with a high prevalence of elevated iron stores. Am J Clin Nutr 73:638–646
Liu J-M, Hankinson SE, Stampfer MJ, Rifai N, Willett WC, Ma J (2003) Body iron stores and their determinants in healthy postmenopausal women. Am J Clin Nutr 78:1160–1167
Beutler E (1998) Targeted disruption of the HFE gene. Proc Natl Acad Sci USA 95:2033–2034
Wright RM, McManaman JL, Repine JE (1999) Alcohol-induced breast cancer: a proposed mechanism. Free Rad Biol Med 26:348–354
Thompson HJ, Kennedy K, Witt M, Juzefyk J (1991) Effect of dietary iron deficiency or excess on the induction of mammary carcinogenesis by 1-methyl-1-nitrosourea. Carcinogenesis 12:111–114
Diwan BA, Kasprzak KS, Anderson LM (1997) Promotion of dimethylbenz[a]anthracene-initiated mammary carcinogenesis by iron in female Sprague-Dawley rats. Carcinogenesis 18:1757–1762
Singh M, Lu J, Briggs SP, McGinley JN, Haegele AD, Thompson HJ (1994) Effect of excess dietary iron on the promotion stage of 1-methyl-1-nitrosourea-induced mammary carcinogenesis: pathogenetic characteristics and distribution of iron. Carcinogenesis (Lond.) 15:1567–1570
Hrabinski D, Hertz JL, Tantillo C, Berger V, Sherman AR (1995) Iron repletion attenuates the protective effects of iron deficiency in DMBA-induced mammary tumors in rats. Nutr Cancer 24:133–142
Hann HW, Stahlhut MW, Blumberg BS (1988) Iron nutrition and tumor growth: decreased tumor growth in iron deficient mice. Cancer Res 48:4168–4170
Wang F, Elliott RL, Head JF (1999) Inhibitory effect of deferoxamine mesylate and low iron diet on the 13762NF rat mammary adenocarcinoma. Anticancer Res 19:445–450
Ho E (2004) Zinc deficiency, DNA damage and cancer risk. J Nutr Biochem 15:572–578
Conte D, Narindrasorasak S, Sarkar B (1996) In vivo and in vitro iron-replaced zinc finger generates free radicals and causes DNA damage. J Biol Chem 271:5125–5130
Oteiza PI, Olin KL, Fraga CG, Keen CL (1995) Zinc deficiency causes oxidative damage to proteins, lipids and DNA in rat testes. J Nutr 125:823–829
Ho E, Courtemanche C, Ames BN (2003) Zinc deficiency induces oxidative DNA damage and increases p53 expression in human lung fibroblasts. J Nutr 133:2543–2548
Ho E, Ames BN (2002) Low intracellular zinc induces oxidative DNA damage, disrupts p53, NFκB, and AP1 DNA binding, and affects DNA repair in a rat glioma cell line. Proc Natl Acad Sci USA 99:16770–16775
Weinberg ED (1996) The role of iron in cancer. Europ J Cancer Prev 5:19–36
Weinstein RE, Bond BH, Silberberg BK (1982) Tissue ferritin concentration in carcinoma of the breast. Cancer 50:2406–2409
Elliott RL, Elliott MC, Wang F, Head JF (1993) Breast carcinoma and the role of iron metabolism: a cytochemical, tissue culture, and ultrastructural study. Ann NY Acad Sci 698:159–166
Faulk WP, Hsi B-L, Stevens PJ (1980) Transferrin and transferrin receptors in carcinoma of the breast. Lancet 2:390–392
Rossiello R, Carriero MV, Giordano GG (1984) Distribution of ferritin, transferrin and lactoferrin in breast carcinoma tissue. J Clin Pathol 37:51–55
Marcus DM, Zinberg N (1975) Measurement of serum ferritin by radioimmunoassay: results in normal individuals and patients with breast cancer. J Natl Cancer Inst 55:791–795
Ionescu JG, Novotny J, Stejskal V, Latsch A, Blaurock-Busch E, Eisenmann-Klein M (2006) Increased levels of transition metals in breast cancer tissue. Neuroendocrin Lett 27(1):36–39
Cavalieri E, Chakravarti D, Guttenplan J et al (2006) Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochimica et Biophysica Acta 1766:63–78
Smith-Warner SA, Spiegelman D, Yaun SS et al (1998) Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA 18: 279:535–540
Ioannou GN, Dominitz JA, Weiss NS, Heagerty PJ, Kowdley KV (2004) The effect of alcohol consumption on the prevalence of iron overload, iron deficiency, and iron deficiency anemia. Gastroenterology 126:1293–1301
Whitfield JB, Zhu G, Heath AC, Powell LW, Martin NG (2001) Effects of alcohol consumption on indices of iron stores and iron stores on alcohol intake markers. Alcohol Clin Exp Res 25:1037–1045
Jacques PF, Sulsky S, Hartz SC, Russell RM (1989) Moderate alcohol intake and nutritional status in nonalcoholic elderly subjects. Am J Clin Nutr 50:875–883
Ron E (1998) Ionizing radiation and cancer risk: evidence from epidemiology. Radiat Res 150 (Suppl.):S30–S41
Stevens RG, Morris JE, Anderson LE (2000) Hemochromatosis heterozygotes may constitute a radiation-sensitive subpopulation. Radiat Res 153:844–847
Böing H, Martinez L, Frentzel-Beyme R, Oltersdorf U (1985) Regional nutritional pattern and cancer mortality in the Federal Republic of Germany. Nutr Cancer 7:121–130
Chen J, Geissler C, Parpia B, Li J, Campbell CT (1992) Antioxidant status and cancer mortality in China. Int J Epidemiol 21:625–635
Cade J, Thomas E, Vail A (1998) Case–control study of breast cancer in south east England: nutritional factors. J Epidemiol Commun Health 52:105–110
Adzersen K-H, Jess P, Freivogel KW, Gerhard I, Bastert G (2003) Raw and cooked vegetables, fruits, selected micronutrients, and breast cancer risk: a case–control study in Germany. Nutr Cancer 46:131–137
Garland M, Morris JS, Colditz GA et al (1996) Toenail trace element levels and breast cancer: a prospective study. Am J Epidemiol 144:653–660
Lee D-H, Anderson KE, Harnack LJ, Jacobs DR Jr (2004) Dietary iron intake and breast cancer: The Iowa Women’s Heath Study. Proc Amer Assoc Cancer Res 45
Kabat GC, Miller AB, Jain M, Rohan TE (2007) Iron and heme iron intake and risk of breast cancer: a prospective cohort study. Cancer Epidemiol Biomarkers Prev 16:1306–1308
Cui Y, Vogt S, Olson N, Glass AG, Rohan TE (2007) Levels of zinc, selenium, calcium, and iron in benign breast tissue and risk of subsequent breast cancer. Cancer Epidemiol Biomarkers Prev 16:1682–1685. doi: 10.1158/1055-9965.EPI-07-0187
Bradbear RA, Bain C, Siskind V et al (1985) Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases. J Natl Cancer Inst 75:81–84
Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G (1985) Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. New Engl J Med 313:1256–1262
Hunter D. (1990) Biochemical indicators of dietary intake. In: Willett WC (Ed), Nutritional epidemiology, New York: Oxford University Press. pp 143–216
Tappel A (2007) Heme of consumed red meat can act as a catalyst of oxidative damage and could initiate colon, breast and prostate cancers, heart disease and other diseases. Med hypoth 68:562–564
Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE (1991) Dietary effects on breast cancer risk in Singapore. Lancet 337:1197–1200
Toniolo P, Riboli E, Shore RE, Pasternack BS (1994) Consumption of meat, animal products, protein, and fat and risk of breast cancer: a prospective cohort study in New York. Epidemiology 5:391–397
Cho E, Chen WY, Hunter DJ et al (2006) Red meat intake and risk of breast cancer among premenopausal women. Arch Intern Med. 166:2253–2259
Hebert JR, Rosen A (1996) Nutritional, socioeconomic, and reproductive factors in relation to female breast cancer mortality: findings from a cross-national study. Cancer Detect Prev 20:234–244
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kabat, G.C., Rohan, T.E. Does excess iron play a role in breast carcinogenesis? an unresolved hypothesis. Cancer Causes Control 18, 1047–1053 (2007). https://doi.org/10.1007/s10552-007-9058-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-007-9058-9